EPITOPES RECOGNIZED BY HIV-SF2 NEF-SPECIFIC CD4+ T-CELL CLONES GENERATED FROM HIV-1-UNINFECTED DONORS

被引:4
作者
WENTWORTH, PA
BATHURST, I
FEUCHT, PH
ERLICH, HA
STEIMER, KS
机构
[1] CETUS CORP,EMERYVILLE,CA 94068
[2] CHIRON CORP,DEPT CELL BIOL & IMMUNOL,EMERYVILLE,CA 94608
基金
美国国家卫生研究院;
关键词
HIV-1; NEF; T-CELL CLONES;
D O I
10.1016/0264-410X(94)90048-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human T-cell clones with specificity to the HIV-1 nef protein were generated by the in vitro stimulation of peripheral blood mononuclear cells (PBMCs) from HIV-1-seronegative donors with purified nef from the HIV-SF2 isolate produced in genetically engineered yeast. Here the characterization is described of a total of seven discrete clones derived from five different donors. Each clone was CD3+CD4+CD8- as determined by FACS analysis. The epitopes recognized by these clones were identified using synthetic overlapping peptides spanning the entire length of nef. Six discrete helper T-cell epitopes located in five distinct regions of nef were identified by this approach. Three of these epitopes are more than 80% conserved among all HIV-1 nef proteins for which sequence data are available. The remaining epitopes are in regions of nef that vary among isolates. Many of the epitopes recognized by our clones overlap T-cell epitopes identified by others examining T-cell responses to nef in HIV-1-infected patients and immunized animals. Using partially class II-matched EBV-transformed B-cell lines, we were able to identify five different HLA class II alleles which encode restricting elements for the in vitro nef-specific proliferative response of these clones (DR1, DRw15(2), DRw6, DQw7, DP5).
引用
收藏
页码:117 / 128
页数:12
相关论文
共 71 条
[1]   PRIMING OF CD4+ T-CELLS SPECIFIC FOR CONSERVED REGIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS GLYCOPROTEIN GP120 IN HUMANS IMMUNIZED WITH A RECOMBINANT ENVELOPE PROTEIN [J].
ABRIGNANI, S ;
MONTAGNA, D ;
JEANNET, M ;
WINTSCH, J ;
HAIGWOOD, NL ;
SHUSTER, JR ;
STEIMER, KS ;
CRUCHAUD, A ;
STAEHELIN, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6136-6140
[2]  
AHMAD N, 1988, SCIENCE, V241, P1418
[3]   GENETIC-VARIABILITY OF THE AIDS VIRUS - NUCLEOTIDE-SEQUENCE ANALYSIS OF 2 ISOLATES FROM AFRICAN PATIENTS [J].
ALIZON, M ;
WAINHOBSON, S ;
MONTAGNIER, L ;
SONIGO, P .
CELL, 1986, 46 (01) :63-74
[4]   A NEW HTLV-III LAV ENCODED ANTIGEN DETECTED BY ANTIBODIES FROM AIDS PATIENTS [J].
ALLAN, JS ;
COLIGAN, JE ;
LEE, TH ;
MCLANE, MF ;
KANKI, PJ ;
GROOPMAN, JE ;
ESSEX, M .
SCIENCE, 1985, 230 (4727) :810-813
[5]   ANTIBODIES TO THE NEF PROTEIN AND TO NEF PEPTIDES IN HIV-1-INFECTED SERONEGATIVE INDIVIDUALS [J].
AMEISEN, JC ;
GUY, B ;
CHAMARET, S ;
LOCHE, M ;
MOUTON, Y ;
NEYRINCK, JL ;
KHALIFE, J ;
LEPREVOST, C ;
BEAUCAIRE, G ;
BOUTILLON, C ;
GRASMASSE, H ;
MANIEZ, M ;
KIENY, MP ;
LAUSTRIAT, D ;
BERTHIER, A ;
MACH, B ;
MONTAGNIER, L ;
LECOCQ, JP ;
CAPRON, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (03) :279-291
[6]   IMMUNOGENICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) RECOMBINANT NEF GENE-PRODUCT - MAPPING OF T-CELL AND B-CELL EPITOPES IN IMMUNIZED CHIMPANZEES [J].
BAHRAOUI, E ;
YAGELLO, M ;
BILLAUD, JN ;
SABATIER, JM ;
GUY, B ;
MUCHMORE, E ;
GIRARD, M ;
GLUCKMAN, JC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (09) :1087-1098
[7]   ANTIGENICITY AND IMMUNOGENICITY OF DOMAINS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ENVELOPE POLYPEPTIDE EXPRESSED IN THE YEAST SACCHAROMYCES-CEREVISIAE [J].
BARR, PJ ;
STEIMER, KS ;
SABIN, EA ;
PARKES, D ;
GEORGENASCIMENTO, C ;
STEPHANS, JC ;
POWERS, MA ;
GYENES, A ;
VANNEST, GA ;
MILLER, ET ;
HIGGINS, KW ;
LUCIW, PA .
VACCINE, 1987, 5 (02) :90-+
[8]   CONSTRUCTION OF PEPTIDES ENCOMPASSING MULTIDETERMINANT CLUSTERS OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE TO INDUCE INVITRO T-CELL RESPONSES IN MICE AND HUMANS OF MULTIPLE MHC TYPES [J].
BERZOFSKY, JA ;
PENDLETON, CD ;
CLERICI, M ;
AHLERS, J ;
LUCEY, DR ;
PUTNEY, SD ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (03) :876-884
[9]  
BERZOFSKY JA, 1987, ANTIGENS, V7, P1
[10]  
BUGAWAN TL, 1988, J IMMUNOL, V141, P4024